ScholarLens Back to search
2001•ACP Journal ClubRequires access

Cilostazol increased walking distance but had more adverse effects than did pentoxifylline in intermittent claudication

Jonathan Michaels

Open publisher page 0 citations

Abstract

Source Citation Dawson DL, Cutler BS, Hiatt WR, et al. A comparison of cilostazol and pentoxifylline for treating intermittent claudication. Am J Med. 2000 Nov;109:523-30. 11063952 (All 2001 articles were reviewed for relevancy, and abstracts were last revised in 2007.)

About this research paper

What this paper is about

Source Citation Dawson DL, Cutler BS, Hiatt WR, et al. A comparison of cilostazol and pentoxifylline for treating intermittent claudication. Am J Med. 2000 Nov;109:523-30. 11063952 (All 2001 articles were reviewed for relevancy, and abstracts were last revised in 2007.)

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Source Citation Dawson DL, Cutler BS, Hiatt WR, et al. A comparison of cilostazol and pentoxifylline for treating intermittent claudication. Am J Med. 2000 Nov;109:523-30. 11063952 (All 2001 articles were reviewed for relevancy, and abstracts were last revised in 2007.)

Key concepts: Cilostazol, Pentoxifylline, Medicine, Intermittent claudication, Claudication, Cardiology, Internal medicine, Physical therapy

Related papers

Related paper 1Related paper 2
Back to paper searchBrowse research topicsOriginal source
Cilostazol increased walking distance but had more adverse effects than did pentoxifylline in intermittent claudication — Research Paper | ScholarLens